THE PHARMACOLOGY HESI 315 EXAM 300 ACTUAL
QUESTIONS AND CORRECT ANSWERS WITH
RATIONALE LATEST UPDATE ALREADY GRADED A+
ASSURED PASS
The Pharmacology HESI 315 exam is a comprehensive nursing assessment
evaluating pharmacotherapeutic knowledge across medication classifications,
including cardiovascular, endocrine, neurologic, psychiatric, anti-infective,
respiratory, gastrointestinal, and pain management agents. The exam tests
understanding of pharmacokinetics, pharmacodynamics, drug interactions, side
effects, nursing interventions, and patient education. Candidates must demonstrate
proficiency in dosage calculations, medication safety, and special population
considerations (pediatrics, geriatrics, pregnancy, renal/hepatic impairment).
Questions emphasize clinical application, requiring recognition of therapeutic
effects, adverse reactions, and appropriate nursing actions. Success requires
knowledge of antidotes, drug-drug interactions, and monitoring parameters. The
exam aligns with HESI testing standards, preparing nursing students for licensure
and safe medication administration practice across diverse patient care settings.
Section 1: Pharmacokinetics and Pharmacodynamics (Questions 1-20)
Question 1
A large volume of distribution (Vd) for a drug indicates that the drug is:
A) Highly protein bound and remains in the bloodstream
B) Extensively distributed into tissues beyond the plasma compartment
C) Poorly absorbed from the gastrointestinal tract
D) Primarily eliminated through renal excretion
Answer: B
,Rationale: A large volume of distribution indicates that the drug is extensively
distributed into tissues beyond the plasma compartment. This means the drug is
highly lipid-soluble and has left the bloodstream to accumulate in fat and other
tissues. A large Vd may also indicate that the drug is not highly protein bound .
Question 2
A medication has a half-life of 12 hours. Approximately how long will it take for
the drug to reach steady state?
A) 12 hours
B) 24 hours
C) 60 hours
D) 120 hours
Answer: C
Rationale: Steady state is typically achieved after approximately 5 half-lives. With
a half-life of 12 hours, steady state would be reached in approximately 60 hours (5
× 12 hours = 60 hours). At steady state, drug administration equals drug
elimination, and plasma concentrations remain relatively constant .
Question 3
A client is prescribed a medication that is highly protein bound. Which condition
would most likely increase the risk of toxicity?
A) Hyperalbuminemia
B) Hypoalbuminemia
C) Decreased renal function
D) Increased hepatic function
Answer: B
Rationale: Hypoalbuminemia (low serum albumin) reduces the number of protein
binding sites for highly protein-bound drugs. This results in more free (unbound,
active) drug in the circulation, increasing the risk of toxicity. Decreased renal
function would affect drug elimination, not protein binding .
Question 4
The nurse is administering a medication that is an antagonist at the beta-1 receptor.
Which effect should the nurse expect?
A) Increased heart rate
B) Decreased heart rate and contractility
,C) Vasodilation
D) Bronchodilation
Answer: B
Rationale: Beta-1 receptor antagonists block the effects of catecholamines at beta-1
receptors in the heart. This results in decreased heart rate and decreased myocardial
contractility. Beta-1 antagonists are used to treat hypertension, angina, and heart
failure .
Question 5
The nurse reviews a client's laboratory results before a procedure in which a
neuromuscular blocking agent is ordered. Which finding should the nurse report to
the healthcare provider?
A) Hypokalemia
B) Hyponatremia
C) Hypercalcemia
D) Hypomagnesemia
Answer: A
Rationale: Hypokalemia increases the risk of adverse effects and prolonged
neuromuscular blockade when neuromuscular blocking agents are given.
Electrolyte imbalances, especially low potassium, affect nerve and muscle
excitability. Reporting hypokalemia allows correction before the procedure to
prevent complications .
---
Section 2: Cardiovascular Medications (Questions 6-60)
Question 6
A client with heart failure is prescribed digoxin 0.25 mg PO daily. Which finding
requires immediate intervention?
A) Apical pulse of 58 beats per minute
B) Serum potassium of 4.0 mEq/L
C) Urine output of 30 mL/hr
D) Weight gain of 1 lb in 2 days
Answer: A
, Rationale: Digoxin toxicity risk increases with heart rate below 60 beats per
minute in adults. The drug should be held and the provider notified. Potassium 4.0
is normal, urine output 30 mL/hr is adequate, and 1 lb gain in 2 days is not
emergent .
Question 7
Which change in data indicates to the nurse that the desired effect of the
angiotensin II receptor antagonist valsartan has been achieved?
A) Dependent edema reduced from +3 to +
B) Serum HDL increased from 35 to 55 mg/dL
C) Pulse rate reduced from 150 to 90 beats/minute
D) Blood pressure reduced from 160/90 to 130/80 mmHg
Answer: D
Rationale: Valsartan is an angiotensin II receptor blocker (ARB) used to treat
hypertension. The desired therapeutic effect is a reduction in blood pressure. A
decrease from 160/90 to 130/80 mmHg indicates that the medication is achieving
its intended effect .
Question 8
When caring for a client on digoxin therapy, the nurse knows to be alert for
digoxin toxicity. Which finding would predispose this client to developing digoxin
toxicity?
A) Low serum sodium level
B) High serum sodium level
C) Low serum potassium level
D) High serum potassium level
Answer: C
Rationale: Hypokalemia potentiates digoxin toxicity because potassium and
digoxin compete for binding sites on the sodium-potassium ATPase pump. Low
potassium levels increase digoxin binding and toxicity risk. Monitoring and
correcting electrolytes are critical in patients on digoxin .
Question 9
The nurse prepares to administer a scheduled dose of labetalol by mouth to a client
with hypertension. The client's vital signs are temperature 99°F (37.2°C), heart rate
QUESTIONS AND CORRECT ANSWERS WITH
RATIONALE LATEST UPDATE ALREADY GRADED A+
ASSURED PASS
The Pharmacology HESI 315 exam is a comprehensive nursing assessment
evaluating pharmacotherapeutic knowledge across medication classifications,
including cardiovascular, endocrine, neurologic, psychiatric, anti-infective,
respiratory, gastrointestinal, and pain management agents. The exam tests
understanding of pharmacokinetics, pharmacodynamics, drug interactions, side
effects, nursing interventions, and patient education. Candidates must demonstrate
proficiency in dosage calculations, medication safety, and special population
considerations (pediatrics, geriatrics, pregnancy, renal/hepatic impairment).
Questions emphasize clinical application, requiring recognition of therapeutic
effects, adverse reactions, and appropriate nursing actions. Success requires
knowledge of antidotes, drug-drug interactions, and monitoring parameters. The
exam aligns with HESI testing standards, preparing nursing students for licensure
and safe medication administration practice across diverse patient care settings.
Section 1: Pharmacokinetics and Pharmacodynamics (Questions 1-20)
Question 1
A large volume of distribution (Vd) for a drug indicates that the drug is:
A) Highly protein bound and remains in the bloodstream
B) Extensively distributed into tissues beyond the plasma compartment
C) Poorly absorbed from the gastrointestinal tract
D) Primarily eliminated through renal excretion
Answer: B
,Rationale: A large volume of distribution indicates that the drug is extensively
distributed into tissues beyond the plasma compartment. This means the drug is
highly lipid-soluble and has left the bloodstream to accumulate in fat and other
tissues. A large Vd may also indicate that the drug is not highly protein bound .
Question 2
A medication has a half-life of 12 hours. Approximately how long will it take for
the drug to reach steady state?
A) 12 hours
B) 24 hours
C) 60 hours
D) 120 hours
Answer: C
Rationale: Steady state is typically achieved after approximately 5 half-lives. With
a half-life of 12 hours, steady state would be reached in approximately 60 hours (5
× 12 hours = 60 hours). At steady state, drug administration equals drug
elimination, and plasma concentrations remain relatively constant .
Question 3
A client is prescribed a medication that is highly protein bound. Which condition
would most likely increase the risk of toxicity?
A) Hyperalbuminemia
B) Hypoalbuminemia
C) Decreased renal function
D) Increased hepatic function
Answer: B
Rationale: Hypoalbuminemia (low serum albumin) reduces the number of protein
binding sites for highly protein-bound drugs. This results in more free (unbound,
active) drug in the circulation, increasing the risk of toxicity. Decreased renal
function would affect drug elimination, not protein binding .
Question 4
The nurse is administering a medication that is an antagonist at the beta-1 receptor.
Which effect should the nurse expect?
A) Increased heart rate
B) Decreased heart rate and contractility
,C) Vasodilation
D) Bronchodilation
Answer: B
Rationale: Beta-1 receptor antagonists block the effects of catecholamines at beta-1
receptors in the heart. This results in decreased heart rate and decreased myocardial
contractility. Beta-1 antagonists are used to treat hypertension, angina, and heart
failure .
Question 5
The nurse reviews a client's laboratory results before a procedure in which a
neuromuscular blocking agent is ordered. Which finding should the nurse report to
the healthcare provider?
A) Hypokalemia
B) Hyponatremia
C) Hypercalcemia
D) Hypomagnesemia
Answer: A
Rationale: Hypokalemia increases the risk of adverse effects and prolonged
neuromuscular blockade when neuromuscular blocking agents are given.
Electrolyte imbalances, especially low potassium, affect nerve and muscle
excitability. Reporting hypokalemia allows correction before the procedure to
prevent complications .
---
Section 2: Cardiovascular Medications (Questions 6-60)
Question 6
A client with heart failure is prescribed digoxin 0.25 mg PO daily. Which finding
requires immediate intervention?
A) Apical pulse of 58 beats per minute
B) Serum potassium of 4.0 mEq/L
C) Urine output of 30 mL/hr
D) Weight gain of 1 lb in 2 days
Answer: A
, Rationale: Digoxin toxicity risk increases with heart rate below 60 beats per
minute in adults. The drug should be held and the provider notified. Potassium 4.0
is normal, urine output 30 mL/hr is adequate, and 1 lb gain in 2 days is not
emergent .
Question 7
Which change in data indicates to the nurse that the desired effect of the
angiotensin II receptor antagonist valsartan has been achieved?
A) Dependent edema reduced from +3 to +
B) Serum HDL increased from 35 to 55 mg/dL
C) Pulse rate reduced from 150 to 90 beats/minute
D) Blood pressure reduced from 160/90 to 130/80 mmHg
Answer: D
Rationale: Valsartan is an angiotensin II receptor blocker (ARB) used to treat
hypertension. The desired therapeutic effect is a reduction in blood pressure. A
decrease from 160/90 to 130/80 mmHg indicates that the medication is achieving
its intended effect .
Question 8
When caring for a client on digoxin therapy, the nurse knows to be alert for
digoxin toxicity. Which finding would predispose this client to developing digoxin
toxicity?
A) Low serum sodium level
B) High serum sodium level
C) Low serum potassium level
D) High serum potassium level
Answer: C
Rationale: Hypokalemia potentiates digoxin toxicity because potassium and
digoxin compete for binding sites on the sodium-potassium ATPase pump. Low
potassium levels increase digoxin binding and toxicity risk. Monitoring and
correcting electrolytes are critical in patients on digoxin .
Question 9
The nurse prepares to administer a scheduled dose of labetalol by mouth to a client
with hypertension. The client's vital signs are temperature 99°F (37.2°C), heart rate
